Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.

BMC Cancer · 2018 · PMC6085616 · PMID 30092781

Europe PMC DOI

hedged sentences

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

did not reach statistical significancep = 0.073so close (0.05 < p ≤ 0.1)

1-year-mortality was higher in patients treated with SBRT compared to TACE patients but did not reach statistical significance (38.4% vs. 53.1%, p = 0.073, Table 3 ).

also in 111,027 other papers

showed a trendno p-value reported

Our sub-group analyses in the matched cohort showed a trend to a higher 1-year-mortality in BCLC C patients treated with TACE compared to SBRT while LC was by trend higher in SBRT treated patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.